{"chunk_type":"transcript_chunk","text":"## 3. Deep Dive: Specific Scenarios & Management ğŸ’Š\n### A. Pediatric Migraine (ì†Œì•„ í¸ë‘í†µ) ğŸ‘¶\n- **Trap:** ì„±ì¸ê³¼ ë‹¬ë¦¬ **Bilateral (Bi-frontal)**ì¸ ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤!\n    - ì–´ë¥¸ì€ í•œìª½, ì• ë“¤ì€ ì´ë§ˆ ì „ì²´.\n- **Duration:** ì„±ì¸ë³´ë‹¤ ì§§ìŠµë‹ˆë‹¤.\n- **Sx:** ë³µí†µ(Abdominal migraine), êµ¬í† , ì–´ì§€ëŸ¬ì›€ ë“±ì´ ë™ë°˜ë  ìˆ˜ ìˆìŒ. ì–´ë¦°ì´ì—ì„œì˜ í¸ë‘í†µì€ ì„±ì¸ì—ì„œì˜ cluster headacheì™€ ë¹„ìŠ·í•¨.\n### B. Migraine in Pregnancy (ì„ì‚°ë¶€ í¸ë‘í†µ) ğŸ¤°\nì„ì‹  ì¤‘ ì•½ë¬¼ ì‚¬ìš©ì€ **Escalation Ladder**ë¥¼ ë”°ë¼ì•¼ í•©ë‹ˆë‹¤. íƒœì•„ ì•ˆì „ì´ ìµœìš°ì„ !\n- **Step 1:** **Non-pharmacologic** (íœ´ì‹, ìˆ˜ë¶„ ì„­ì·¨, ì°œì§ˆ) - Trigger í”¼í•˜ê¸°.\n- **Step 2:** **Acetaminophen (Tylenol)** - All trimesters ì•ˆì „.\n- **Step 3:** Antiemetics (Promethazine), Codeine, Caffeine.\n- **Step 4 (WARNING âš ï¸):** **NSAIDs** (Ibuprofen, Naproxen)\n    - **2nd Trimester ONLY.**\n    - **3rd Trimester ê¸ˆê¸°:** íƒœì•„ì˜ **Ductus Arteriosus(ë™ë§¥ê´€)**ë¥¼ ì¡°ê¸°ì— ë‹«ì•„ë²„ë ¤ íƒœì•„ ìˆœí™˜ì— ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŒ.\n- **Step 5 (Last Resort):** Opioids (Oxycodone) - ìƒë¦¬ì ìœ¼ë¡œëŠ” 3ê¸° NSAIDë³´ë‹¤ ì‹¬ì¥ì— ì•ˆì „í• ì§€ ëª°ë¼ë„ ìµœí›„ì˜ ìˆ˜ë‹¨.\n### C. Cluster Headache Treatment\n- **Acute (Abortive) â˜…:** **100% High-Flow Oxygen** (6-12L/min for 15 min). ì´ê²ƒì´ **Gold Standard**ì…ë‹ˆë‹¤. ì•½ë³´ë‹¤ ë¹ ë¦„!\n    - Alternative: Sumatriptan (Subcutaneous) - ì£¼ì‚¬ë¼ ë¹ ë¦„.\n- **Prophylaxis (Preventive):** **Verapamil** (Calcium Channel Blocker) is the drug of choice.\n### D. Drug Interactions (Black Box Warning â¬›)\n- **Triptan + Ergot:** ì ˆëŒ€ ê°™ì´ ì“°ë©´ ì•ˆ ë¨! ë‘˜ ë‹¤ í˜ˆê´€ ìˆ˜ì¶•ì œ(Vasoconstrictor)ì…ë‹ˆë‹¤.\n    - ë™ì‹œì— ì“°ë©´ **Coronary Vasospasm** (MI) ë˜ëŠ” **Stroke** ìœ ë°œ ê°€ëŠ¥.\n    - ë°˜ë“œì‹œ \"Washout period\"ê°€ í•„ìš”í•¨.\n---\n## 4. Medication Overuse Headache (Rebound Headache) ğŸ”„\n- **Concept:** ì§„í†µì œë¥¼ ë„ˆë¬´ ìì£¼ ë¨¹ì–´ì„œ, ì•½íš¨ê°€ ë–¨ì–´ì§ˆ ë•Œ ê¸ˆë‹¨ ì¦ìƒ(Withdrawal)ìœ¼ë¡œ ë‘í†µì´ ë” ì‹¬í•˜ê²Œ ì˜¤ëŠ” í˜„ìƒ.\n- **Definition:** Pain medication use **> every other day** (ê²©ì¼ ì´ìƒ ì‚¬ìš©).\n- **Culprits:** Butalbital, Opioids, Acetaminophen (ì‹¬ì§€ì–´ íƒ€ì´ë ˆë†€ë„!), Triptans.\n- **Management:**\n    1. **Stop the offending agent** (Cessation).\n    2. Start preventive therapy immediately.\n    3. í™˜ìì—ê²Œ \"ì²˜ìŒì—” ë” ì•„í”Œ ìˆ˜ ìˆë‹¤\"ê³  êµìœ¡í•´ì•¼ í•¨.\n---\n## 5. Secondary Headaches: The \"Thunderclap\" âš¡ï¸ğŸš¨\n**Definition:** \"Sudden onset, severe headache reaching **maximum intensity** in less than 1 hour (usually seconds to minutes).\"\n### Etiology (The \"Zebras\" & Killers)\n1. **SAH (Subarachnoid Hemorrhage):** ê°€ì¥ í”í•˜ê³  ìœ„í—˜í•¨. \"ê³ í˜ˆì••í™˜ìê°€ ë’·ëª©ì´ ë»£ë»£í•¨(Nuchal rigidity)\".\n2. **RCVS (Reversible Cerebral Vasoconstriction Syndrome):** ë°˜ë³µì ì¸ ë²¼ë½ ë‘í†µ\n3. **Pituitary Apoplexy (ë‡Œí•˜ìˆ˜ì²´ ì¡¸ì¤‘):**\n    - ë‡Œí•˜ìˆ˜ì²´ë¡œ ì¶œí˜ˆ ë°œìƒ. Optic Chiasm ì••ë°•.\n    - **Signs:** **Ophthalmoplegia** (ëˆˆ ì›€ì§ì„ ë§ˆë¹„), **Visual Field Defects** (Tunnel vision), Signs of Adrenal Crisis (ì €í˜ˆì••).\n4. **Cervical Artery Dissection:** ëª© ì™¸ìƒ í›„ ë°œìƒ.\n5. **CVST (Cavernous Sinus Thrombosis):** ì•ˆêµ¬ ëŒì¶œ(Proptosis), ê³ ì—´, ê°ì—¼ ì§•í›„ ë™ë°˜.\n### Workup Protocol (The Algorithm) âš™ï¸\nThunderclap í™˜ìê°€ ì˜¤ë©´ ì´ ìˆœì„œë¥¼ ì ˆëŒ€ ì–´ê¸°ë©´ ì•ˆ ë©ë‹ˆë‹¤!","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-191","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"1. **Step 1:** **Non-contrast CT Head**\n    - Subarachnoid spaceì˜ í”¼ë¥¼ ë´…ë‹ˆë‹¤.\n    - *Scenario:* CTê°€ ê¹¨ë—í•¨(Negative). ì§‘ì— ë³´ë‚´ë„ ë˜ë‚˜? **NO!** ğŸ™…â€â™‚ï¸\n2. **Step 2:** **Lumbar Puncture (LP)**\n    - ì‘ì€ ì¶œí˜ˆ(Small bleed)ì€ CTì—ì„œ ì•ˆ ë³´ì¼ ìˆ˜ ìˆìŒ.\n    - **Look for:** **Xanthochromia** (ë…¸ë€ìƒ‰ ë‡Œì²™ìˆ˜ì•¡ - ì í˜ˆêµ¬ê°€ ê¹¨ì ¸ì„œ ë¹Œë¦¬ë£¨ë¹ˆì´ ëœ ê²ƒ).\n3. **Step 3:** **MRI Brain**\n    - CT, LP ë‘˜ ë‹¤ ì• ë§¤í•˜ê±°ë‚˜ ìŒì„±ì¸ë° ì˜ì‹¬ë˜ë©´ MRI.\n---\n## ğŸ”¥ Rapid Fire Recap: High-Yield Associations\n| **Clue in Question** | **Diagnosis** | **Next Step / Treatment** |\n| --- | --- | --- |\n| \"Worst headache of my life\" | **SAH** (Thunderclap) | Non-contrast CT â†’ LP |\n| Male, pacing around room, holding eye | **Cluster Headache** | **100% Oxygen** (First line) |\n| Female, pulsatile pain, vomiting, dark room | **Migraine** | Triptan (Abortive) / Beta-blocker (Prevent) |\n| Band-like pressure, \"tight hat\" | **Tension Headache** | NSAIDs / Relaxation |\n| Pregnant (3rd Tri) with Migraine | **Migraine** | **Avoid NSAIDs!** (Use Tylenol/Opioids) |\n| Child with \"Bi-frontal\" headache | **Pediatric Migraine** | Rest, Hydration, Tylenol |\n| Headache + Visual field cut + Hypotension | **Pituitary Apoplexy** | Urgent Surgical Consult / Steroids |\n---\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” Pediatric Migraineì´ \"Bifrontal\"ì´ë¼ê³  ê°•ì¡°í–ˆì§€ë§Œ, ì‹¤ì œ ì„ìƒì—ì„œëŠ” ë‹¤ì–‘í•  ìˆ˜ ìˆìœ¼ë‹ˆ Board Exam íŒíŠ¸ë¡œ ê¸°ì–µí•˜ì„¸ìš”.\n    - Cluster Headache ì¹˜ë£Œì—ì„œ ì‚°ì†Œ ì¹˜ë£Œê°€ \"Gold Standard\"ë¼ê³  í–ˆì§€ë§Œ, ë§Œì„± íì§ˆí™˜(COPD) í™˜ìì—ê²ŒëŠ” ì£¼ì˜ê°€ í•„ìš”í•  ìˆ˜ ìˆë‹¤ëŠ” ì (ì˜¤ë””ì˜¤ì—” ì—†ì§€ë§Œ ì˜í•™ì  ìƒì‹)ì„ ì—¼ë‘ì— ë‘ì„¸ìš”.\n    - ì„ì‹  ì¤‘ NSAID ê¸ˆê¸°ëŠ” 3ë¶„ê¸°(3rd Trimester)ê°€ ê°€ì¥ ì¹˜ëª…ì ì…ë‹ˆë‹¤.\n**Next Step for User:** Would you like me to generate a **\"USMLE Style Vignette Quiz\"** based on these notes to test your retention? ğŸ“\n**Next Step for User:** Would you like me to generate a **\"USMLE Style Vignette Quiz\"** based on these notes to test your retention? ğŸ“\n---\n# ğŸ§  USMLE Top-down Classification: Seizure & Epilepsy\nì•ˆë…•í•˜ì„¸ìš”! ğŸ‘¨â€âš•ï¸ Deep Dive Audioë¥¼ ë°”íƒ•ìœ¼ë¡œ ì •ë¦¬í•œ Epilepsy & Seizure Management ë…¸íŠ¸ì…ë‹ˆë‹¤. ì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ë‹¨ìˆœíˆ ì•½ë¬¼ ì•”ê¸°ê°€ ì•„ë‹ˆë¼, **\"Time is Brain\"**ì´ë¼ëŠ” ìƒë¦¬í•™ì  ìœ„ê¸° ìƒí™©ì„ ë‹¤ë£¹ë‹ˆë‹¤.\në¨¼ì €, ì „ì²´ì ì¸ **Big Picture**ë¥¼ ASCII Treeë¡œ ì¡ê³  ë“¤ì–´ê°‘ì‹œë‹¤!\nPlaintext\n`[Concept: Electrical Storm of the Brain]\n      |\n      +-- 1. Physiological Crisis (Status Epilepticus) ğŸš‘\n      |     |-- Definition: Seizure > 5 mins (OLD: 30 mins)\n      |     |-- Pathophysiology: Glutamate storm -> Ca2+ influx -> Cell Death\n      |     +-- MGT: Benzodiazepine -> Anti-epileptics -> Anesthesia\n      |\n      +-- 2. Seizure Classification (By Onset)\n      |     |\n      |     +-- A. Focal Seizures (Partial)\n      |     |     |-- Origin: One Hemisphere\n      |     |     |-- Awareness Intact (Simple Partial)\n      |     |     +-- Awareness Impaired (Complex Partial) -> Automatism\n      |     |\n      |     +-- B. Generalized Seizures\n      |           |-- Origin: Both Hemispheres\n      |           |-- Tonic-Clonic (Grand Mal)\n      |           |-- Absence (Petit Mal) -> 3Hz Spike & Wave âš¡\n      |           +-- Myoclonic / Atonic\n      |\n      +-- 3. Differential Diagnosis (The Impostors)\n            +-- Syncope vs. Seizure (Key: Post-ictal State â˜…)\n            +-- Psychogenic Non-Epileptic Seizures (PNES)`\n---\n# H1: 1. The Framework: \"Time is Brain\" â³ğŸ§ \nì´ ì±•í„°ì˜ í•µì‹¬ì€ **Seizure Managementì˜ ìŠ¤í™íŠ¸ëŸ¼**ì„ ì´í•´í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ìˆ˜í•™ ì‹œê°„ì— ë©ë•Œë¦¬ëŠ” ì•„ì´ë¶€í„°, ì‘ê¸‰ì‹¤ì—ì„œ ê²½ë ¨ì„ ë©ˆì¶”ì§€ ì•ŠëŠ” í™˜ìê¹Œì§€ ëª¨ë‘ 'Seizure'ë¼ëŠ” ìš°ì‚° ì•„ë˜ ìˆìŠµë‹ˆë‹¤.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-211","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸšª Doorway Thoughts (Mental Imagery)\nì˜¤ë””ì˜¤ì—ì„œëŠ” ë‘ ê°€ì§€ ìƒë°˜ëœ ì´ë¯¸ì§€ë¥¼ ì œì‹œí•˜ì—¬ ìŠ¤í™íŠ¸ëŸ¼ì„ ì„¤ëª…í•©ë‹ˆë‹¤.\n1. **Scene 1: The Nightmare (Status Epilepticus)** ğŸ‘¹\n    - **Setting:** Trauma Bay, Absolute Chaos.\n    - **Patient:** Stretcher ìœ„ì—ì„œ ê²©ë ¬í•˜ê²Œ ê²½ë ¨ ì¤‘ (Violently convulsing).\n    - **Team:** ì†Œë¦¬ ì§€ë¥´ê³  ìˆê³ , ì‹œê³„ë¥¼ ë³´ê³  ìˆìŒ. \"6ë¶„ì´ ì§€ë‚¬ì–´! ë©ˆì¶”ì§€ ì•Šì•„!\"\n    - **Meaning:** ì´ê²ƒì´ ë°”ë¡œ **Status Epilepticus**. \"Time is Brain\"ì€ ë‹¨ìˆœí•œ ìŠ¬ë¡œê±´ì´ ì•„ë‹ˆë¼ ìƒë¦¬í•™ì  ì‚¬ì‹¤ì…ë‹ˆë‹¤. ë‰´ëŸ°ì´ ì£½ì–´ê°€ê³  ìˆëŠ” ìƒí™©ì…ë‹ˆë‹¤.\n2. **Scene 2: The Quiet Classroom (Absence Seizure)** ğŸ«\n    - **Setting:** ì¡°ìš©í•œ 3í•™ë…„ êµì‹¤.\n    - **Patient:** ì±…ìƒì— ì•‰ì•„ ì¹ íŒì„ ë©í•˜ë‹ˆ ì‘ì‹œí•˜ëŠ” ì•„ì´ (Blank stare).\n    - **Action:** ì„ ìƒë‹˜ì´ ì§ˆë¬¸í•˜ì 10ì´ˆ ë’¤ì— ì•„ì´ê°€ í˜„ì‹¤ë¡œ 'Snap back' í•˜ì—¬ ì—°í•„ì„ ì§‘ì–´ ë“¦. ì“°ëŸ¬ì§€ê±°ë‚˜ ë–¨ì§€ ì•ŠìŒ.\n    - **Meaning:** ì´ê²ƒì€ **Absence Seizure**. ìŠ¤í™íŠ¸ëŸ¼ì˜ ë°˜ëŒ€í¸ ëì— ìˆëŠ” ë¯¸ë¬˜í•œ ë°œì‘ì…ë‹ˆë‹¤.\n# H1: 2. The Workup: Being a Detective ğŸ•µï¸â€â™‚ï¸\ní™˜ìê°€ ë°œì‘ìœ¼ë¡œ ì‹¤ë ¤ì™”ê±°ë‚˜, ë°œì‘ì´ ëë‚œ í›„(Post-ictal) ìƒíƒœì¼ ë•Œ, ìš°ë¦¬ëŠ” **ë°˜ë“œì‹œ ë°°ì œí•´ì•¼ í•  ë¦¬ìŠ¤íŠ¸(Must Exclude List)**ê°€ ìˆìŠµë‹ˆë‹¤. Epilepsy(ë‡Œì „ì¦)ëŠ” ë§Œì„± ì§ˆí™˜ì´ë¯€ë¡œ, ê¸‰ì„± ì›ì¸ë“¤ì„ ë¨¼ì € rule out í•´ì•¼ ì§„ë‹¨í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸš‘ Rule Out Reversible Causes (The Checklist)\n1. **The Heart (ECG) â¤ï¸**\n    - ê°€ì¥ ë¨¼ì € ë´ì•¼ í•  ê³³ì€ ë‡Œê°€ ì•„ë‹ˆë¼ ì‹¬ì¥ì…ë‹ˆë‹¤.\n    - **Why?** Massive Arrhythmia (ì˜ˆ: V-fib) -> ë‡Œë¡œ ê°€ëŠ” í˜ˆë¥˜ ì¤‘ë‹¨ -> ë‡Œì˜ ì €ì‚°ì†Œì¦(Hypoxia) -> ë‡Œì„¸í¬ê°€ ì˜ˆë¯¼í•´ì ¸ì„œ Seizure ìœ ë°œ.\n    - **Clinical Pearl:** ë¶€ì •ë§¥ì„ ë†“ì¹˜ë©´, ì‹¬ì¥ì´ ë©ˆì¶”ê³  ìˆëŠ”ë° ë°œì‘ ì¹˜ë£Œë§Œ í•˜ëŠ” ê¼´ì´ ë©ë‹ˆë‹¤.\n2. **Neuro-Imaging (CT or MRI) ğŸ“¸**\n    - **Goal:** Structural Lesion ë°°ì œ.\n    - **Look for:** Bleed (ì¶œí˜ˆ), Tumor (ì¢…ì–‘), Abscess (ë†ì–‘).\n    - **â˜… The \"First Seizure Rule\" for Adults:**\n        - ë§Œì•½ **50ì„¸ ì´ìƒ ì„±ì¸**ì´ ë‚œìƒì²˜ìŒ ë°œì‘(First-time seizure)ì„ í–ˆë‹¤?\n        - **Brain Tumor (Mass Lesion)** until proven otherwise.\n3. **The Labs (Blood Work) ğŸ©¸**\n    - ë‡ŒëŠ” í¬ë„ë‹¹(Glucose)ìœ¼ë¡œ ëŒì•„ê°‘ë‹ˆë‹¤.\n    - **Hypoglycemia (ì €í˜ˆë‹¹):** ì—°ë£Œ íƒ±í¬ê°€ ë¹„ë©´ ì´ì˜¨ íŒí”„ê°€ ê³ ì¥ ë‚˜ê³ , ë§‰ì „ìœ„ê°€ ë¶ˆì•ˆì •í•´ì ¸ì„œ Seizure ë°œìƒ.\n    - **Electrolytes:**\n        - **Sodium (Na+):** Hyponatremia -> Cerebral Edema (ë‡Œë¶€ì¢…) -> Cortex ìê·¹.\n        - **Calcium (Ca++), Magnesium (Mg++):** ë‚®ìœ¼ë©´ ë‰´ëŸ°ì˜ í¥ë¶„ì„±(Excitability) ì¦ê°€.\n4. **Prolactin (The Lie Detector) ğŸ¤¥**\n    - **Significance:** ì§„ì§œ ëŒ€ë°œì‘(Generalized Tonic-Clonic Seizure) ì§í›„ì—ëŠ” ë‡Œí•˜ìˆ˜ì²´ê°€ ìê·¹ë°›ì•„ Prolactinì„ ìŸì•„ëƒ…ë‹ˆë‹¤.\n    - **Timeline:** ì‹¤ì œ ë°œì‘ í›„ 10~20ë¶„ ë’¤ì— ìˆ˜ì¹˜ê°€ ê¸‰ë“±(Spike)í•¨.\n    - **Clinical Use:** í™˜ìê°€ ë°”ë‹¥ì—ì„œ ë’¹êµ´ì—ˆëŠ”ë° 15ë¶„ ë’¤ Prolactinì´ ì •ìƒì´ë‹¤? -> **Psychogenic (ê°€ì§œ ë°œì‘)** í˜¹ì€ **Syncope**ì¼ ê°€ëŠ¥ì„± ë†’ìŒ.\n5. **Toxicology Screen ğŸ§ª**\n    - **Stimulants:** Cocaine, Amphetamines (Seizure Threshold ë‚®ì¶¤).\n    - **Withdrawal:** Alcohol Withdrawal (ë§ˆì§€ë§‰ ìˆ  ë§ˆì‹œê³  12~48ì‹œê°„ ë’¤ ë°œìƒ). ë°˜ë“œì‹œ ì²´í¬!\n6. **Lumbar Puncture (LP) ğŸ’‰**\n    - **Warning:** ëª¨ë“  í™˜ìì—ê²Œ í•˜ëŠ” ê²ƒì´ ì•„ë‹˜!\n    - **Indication:** **CNS ê°ì—¼(Infection)** ì˜ì‹¬ ì‹œì—ë§Œ ìˆ˜í–‰ (ì—´(Fever), ê²½ë¶€ ê°•ì§(Stiff neck), ë²¼ë½ ë‘í†µ ë“±).\n# H1: 3. Focal Seizures (ë¶€ë¶„ ë°œì‘) ğŸ¯\nFocal SeizureëŠ” ë‡Œì˜ **í•œìª½ ë°˜êµ¬(Hemisphere)**ì—ì„œë§Œ ì „ê¸°ì  ë°©ì „ì´ ì‹œì‘ë˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ì¦ìƒì€ \"ì–´ë””ì„œ ë¶ˆì´ ë‚¬ëŠëƒ\"ì— ë”°ë¼ ë‹¬ë¼ì§‘ë‹ˆë‹¤.\n### A. Symptom Buckets (ì¦ìƒ ë¶„ë¥˜)\n| **Bucket** | **Symptoms** | **Location Example** |\n| --- | --- | --- |\n| **Motor** | **Jacksonian March:** ì—„ì§€ì†ê°€ë½ì´ ë–¨ë¦¬ê¸° ì‹œì‘ -> ì† -> íŒ” -> ì–¼êµ´ë¡œ ë–¨ë¦¼ì´ í–‰ì§„í•˜ë“¯ í¼ì§. (Homunculus ì§€ë„ ë”°ë¼ ì´ë™) | Motor Cortex |\n| **Sensory** | íƒ€ëŠ” ê³ ë¬´ ëƒ„ìƒˆ(Burning rubber), ë²ˆì©ì´ëŠ” ë¹›, í•œìª½ ëª¸ì˜ ë”°ë”ê±°ë¦¼(Pins & needles). | Sensory Cortex / Temporal |\n| **Autonomic** | ì„¤ëª…í•˜ê¸° í˜ë“  ë±ƒì†ì—ì„œ ì¹˜ë¯¸ëŠ” ëŠë‚Œ (Epigastric rising sensation), ì‹ì€ë•€, ì†Œë¦„. | Insula / Deep structures |\n| **Psychic** | **DÃ©jÃ  vu** (ì´ë¯¸ ë³¸ ê²ƒ ê°™ì€ ëŠë‚Œ), ê°‘ì‘ìŠ¤ëŸ¬ìš´ ê³µí¬(Fear), ì„¸ìƒì´ ë‚¯ì„¤ê²Œ ë³´ì„. | **Temporal Lobe** (Limbic system) |\n### B. Classification Update (ìš©ì–´ ì •ë¦¬) ğŸ“\nê³¼ê±°ì—ëŠ” Simple Partial / Complex Partialì´ë¼ê³  ë¶ˆë €ì§€ë§Œ, ì§€ê¸ˆì€ **\"Awareness(ì˜ì‹)\"** ê¸°ì¤€ìœ¼ë¡œ ë¶„ë¥˜í•©ë‹ˆë‹¤.\n1. **Focal Seizure with Intact Awareness (êµ¬ Simple Partial)**\n    - í™˜ìê°€ ê¹¨ì–´ ìˆê³ , ìì‹ ì˜ íŒ”ì´ ë–¨ë¦¬ëŠ” ê²ƒì„ ì¸ì§€í•˜ë©° ëŒ€í™” ê°€ëŠ¥.\n2. **Focal Seizure with Impaired Awareness (êµ¬ Complex Partial)**\n    - ì˜ì‹ì´ íë ¤ì§€ê±°ë‚˜ ë©í•´ì§.\n    - **Automatisms (ìë™ì¦):** ì…ë§› ë‹¤ì‹œê¸°(Lip smacking), ì˜· ë§Œì§€ì‘ê±°ë¦¬ê¸°(Picking at clothes), ë‹¨ì¶” í’€ê¸° ë“± ë¬´ì˜ì‹ì ì¸ ë°˜ë³µ í–‰ë™.\n    - **Scenario:** ë¶ˆì€ ì¼œì ¸ ìˆëŠ”ë° ì§‘ì— ì•„ë¬´ë„ ì—†ëŠ” ìƒíƒœ (Lights are on, but nobody's home).\n---\n# H1: 4. The Great Debate: Syncope vs. Seizure ğŸ¥Š","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-231","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"í™˜ìê°€ ì“°ëŸ¬ì ¸ì„œ ëª¸ì„ ë–¨ì—ˆë‹¤ê³  í•©ë‹ˆë‹¤. ëª©ê²©ìëŠ” \"ë°œì‘í–ˆë‹¤\"ê³  í•˜ì§€ë§Œ, ê·¸ëƒ¥ ê¸°ì ˆ(Syncope)ì¼ ìˆ˜ë„ ìˆìŠµë‹ˆë‹¤. ì–´ë–»ê²Œ êµ¬ë³„í• ê¹Œìš”?\n### ğŸ† The Golden Rule: Post-ictal State\n| **Feature** | **Syncope (ì‹¤ì‹ )** | **Seizure (ë°œì‘)** |\n| --- | --- | --- |\n| **Pathology** | ë‡Œ í˜ˆë¥˜ ì¼ì‹œì  ê°ì†Œ (Low blood flow) | ë‡Œì˜ ì „ê¸°ì  í­í’ (Electrical Storm) |\n| **Recovery** | **Instant Return:** ë°”ë‹¥ì— ë‹¿ìœ¼ë©´ í”¼ê°€ ë‡Œë¡œ ëŒì•„ê°€ì„œ ë°”ë¡œ ê¹¸. ì•½ê°„ ë©í•  ìˆœ ìˆì–´ë„ ê¸ˆë°© ëª…ë£Œí•´ì§ (Crisp awakening). | **Post-ictal Confusion:** ë‡Œê°€ ë§ˆë¼í†¤ì„ ë›´ ìƒíƒœ. ê¹¨ì–´ë‚˜ëŠ” ë° ìˆ˜ë¶„~ìˆ˜ì‹œê°„ ê±¸ë¦¼. í˜¼ë€, ì¡¸ìŒ(Lethargy) ë™ë°˜. |\n| **Shaking** | ìˆì„ ìˆ˜ ìˆìŒ (Convulsive syncope), í•˜ì§€ë§Œ ì§§ìŒ. | ì§€ì†ì ì´ê³  ë¦¬ë“¬ê° ìˆìŒ. |\n# H1: 5. Pediatric Special: Absence Seizures (ê²°ì‹  ë°œì‘) ğŸ§’\n### ğŸšª The Vignette\n- ì„ ìƒë‹˜í•œí…Œ í˜¼ë‚˜ëŠ” ì•„ì´: \"ìˆ˜ì—… ì‹œê°„ì— ë”´ì²­ í”¼ìš°ì§€ ë§ˆ!\"\n- ì‚¬ì‹¤ ì•„ì´ëŠ” ë”´ì²­ í”¼ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼ **Generalized Seizure**ë¥¼ ê²ªê³  ìˆëŠ” ì¤‘.\n### Key Characteristics\n1. **Onset:** ê°‘ì‘ìŠ¤ëŸ¬ìš´ ì˜ì‹ ì†Œì‹¤ (Sudden impairment of consciousness).\n2. **Motor:** ì“°ëŸ¬ì§€ì§€ ì•ŠìŒ (Muscle tone preserved). ê·¸ëƒ¥ ë™ì‘ì´ 'ì¼ì‹œ ì •ì§€(Freeze)' ë¨.\n3. **Duration:** ë§¤ìš° ì§§ìŒ (< 20ì´ˆ).\n4. **No Post-ictal:** ë°œì‘ì´ ëë‚˜ë©´ ë°”ë¡œ í˜„ì‹¤ë¡œ ë³µê·€ (Snap back). ìê¸°ê°€ ë°œì‘í•œ ì¤„ ëª¨ë¦„.\n5. **Provocation:** **Hyperventilation (ê³¼í˜¸í¡)** ì‹œí‚¤ë©´ ìœ ë°œë¨ (ë°”ëŒê°œë¹„ ë¶ˆê²Œ í•˜ê¸°).\n### âš¡ Diagnosis & Treatment\n- **Gold Standard Dx:** **EEG (ë‡ŒíŒŒ)** -> **3Hz Spike and Wave pattern** (ì´ˆë‹¹ 3ë²ˆì˜ ë¾°ì¡±í•œ íŒŒí˜•).\n- **Treatment (DOC):** **Ethosuximide** ğŸ’Š (T-type Calcium channel blocker in Thalamus).\n- **Prognosis:** ëŒ€ë¶€ë¶„ ì‚¬ì¶˜ê¸°(Puberty) ì´ì „ì— ìì—° ì†Œì‹¤ë¨ (Good prognosis).\n### ğŸ†š Contrast with \"Inattentive Staring\" (ë©ë•Œë¦¬ê¸°)\n- **Touch Test:** ë©ë•Œë¦¬ëŠ” ì•„ì´ ì–´ê¹¨ë¥¼ ì¹˜ê±°ë‚˜ ë¶€ë¥´ë©´ \"ì–´? ì™œìš”?\" í•˜ê³  ë°˜ì‘í•¨ (Snaps out with tactile stimulation).\n- **Absence:** ì•„ë¬´ë¦¬ ë¶ˆëŸ¬ë„, ì–´ê¹¨ë¥¼ ì³ë„ ë°˜ì‘ ì—†ìŒ. ë‡Œê°€ ì˜¤í”„ë¼ì¸ ìƒíƒœì„.\n---\n# H1: 6. Status Epilepticus (ë‡Œì „ì¦ì§€ì†ìƒíƒœ) ğŸš¨ğŸ’€\nì—¬ê¸°ê°€ ë°”ë¡œ \"High Voltage Territory\"ì…ë‹ˆë‹¤.\n### Definitions & Pathophysiology\n- **New Definition:** **5ë¶„ ì´ìƒ** ì§€ì†ë˜ëŠ” ë°œì‘ OR ì˜ì‹ íšŒë³µ ì—†ì´ 2íšŒ ì´ìƒ ì—°ì† ë°œì‘.\n    - (ê³¼ê±°ì—ëŠ” 30ë¶„ì´ì—ˆìœ¼ë‚˜, 30ë¶„ ê¸°ë‹¤ë¦¬ë©´ ë‡Œê°€ ë‹¤ íƒ€ë²„ë¦¼).\n- **Why 5 minutes?** ëŒ€ë¶€ë¶„ì˜ ìŠ¤ìŠ¤ë¡œ ë©ˆì¶”ëŠ”(Self-limited) ë°œì‘ì€ 2-3ë¶„ ë‚´ì— ëë‚¨. 5ë¶„ì„ ë„˜ê¸°ë©´ ì‹ ì²´ì˜ 'Stop mechanism'ì´ ê³ ì¥ ë‚œ ê²ƒ.\n- **Physiology:**\n    1. **Cortical Laminar Necrosis:** ë‡Œì„¸í¬ê°€ í¥ë¶„ ë…ì„±(Excitotoxicity)ìœ¼ë¡œ ë…¹ì•„ë‚´ë¦¼.\n    2. **Systemic:** íš¡ë¬¸ê·¼ìœµí•´ì¦(Rhabdomyolysis) -> ì‹ ë¶€ì „(Kidney Failure), ê³ ì—´(Hyperthermia). ë‡Œì™€ ëª¸ì„ ë™ì‹œì— ìš”ë¦¬(Cooking)í•˜ëŠ” ê²ƒê³¼ ê°™ìŒ.\n### ğŸš‘ Management Protocol (The Algorithm)","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-251","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"ì´ ì•Œê³ ë¦¬ì¦˜ì€ ë°˜ë“œì‹œ ìˆœì„œëŒ€ë¡œ ê¸°ì–µí•´ì•¼ í•©ë‹ˆë‹¤. **Step-by-Step!**\n### Step 1: Stabilization (0-5 mins)\n- **ABCs:** Airway, Breathing, Circulation.\n- **Glucose Check:** ì €í˜ˆë‹¹ì´ë©´ Dextrose íˆ¬ì—¬.\n- **Oxygen:** ë‡Œê°€ ì‚°ì†Œë¥¼ ì—„ì²­ë‚˜ê²Œ ì“°ê³  ìˆìœ¼ë¯€ë¡œ ê³µê¸‰ í•„ìˆ˜.\n### Step 2: The First Line (Benzodiazepines) ğŸ’Š\n- **Drug:** **IV Lorazepam** (ë¡œë¼ì œíŒœ).\n- **Alternative:** IV ë¼ì¸ì´ ì—†ë‹¤ë©´? -> **IM Midazolam** (ê·¼ìœ¡ì£¼ì‚¬).\n- **Mechanism:** GABA ìˆ˜ìš©ì²´(Off switch)ë¥¼ ì¼œì„œ ë‡Œë¥¼ ì§„ì •ì‹œí‚´.\n### Step 3: The Second Line (Long-acting Anti-epileptics)\n- ë²¤ì¡°ë¡œ ë¶ˆì„ ê»ìœ¼ë©´, ë‹¤ì‹œ ë¶ˆì´ ë¶™ì§€ ì•Šê²Œ ë°©í™”ë²½ì„ ì³ì•¼ í•¨.\n- **Options:**\n    1. **Levetiracetam (Keppra):** ë¶€ì‘ìš© ì ê³  ìƒí˜¸ì‘ìš© ì ì–´ì„œ ë§ì´ ì”€.\n    2. **Valproic Acid (Valproate):** ê´‘ë²”ìœ„í•˜ê²Œ ì“°ì„.\n    3. **Fosphenytoin:** (Phenytoinì˜ Prodrug). ì‹¬ì¥ ë…ì„± ì£¼ì˜.\n### Step 4: Refractory Status (The \"Nuclear Option\") â˜¢ï¸\n- ì•½ì„ ë‹¤ ì¼ëŠ”ë°ë„ ë°œì‘ì´ ì•ˆ ë©ˆì¶˜ë‹¤ë©´?\n- **Action:** **Intubation** (ì‚½ê´€) + **General Anesthesia** (Propofol, Pentobarbital).\n- **Critical Monitoring:** **Continuous EEG monitoring**.\n    - **Why?** ê·¼ì´ì™„ì œ(Paralytics)ë¥¼ ì“°ë©´ ê²‰ìœ¼ë¡œëŠ” ì•ˆ ë–¨ì§€ë§Œ, ë‡Œ ì•ˆì—ì„œëŠ” ì—¬ì „íˆ ë°œì‘ ì¤‘ì¼ ìˆ˜ ìˆìŒ (**Non-convulsive Status Epilepticus**). ì´ê²ƒì€ \"Silent Killer\"ì„. EEGë¡œ ë‡ŒíŒŒê°€ ì ì í•´ì¡ŒëŠ”ì§€ í™•ì¸í•´ì•¼ í•¨.\n---","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-271","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap Table\në§ˆì§€ë§‰ìœ¼ë¡œ í•µì‹¬ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤. ì¡±ì§‘ê²Œ ê³¼ì™¸ í¬ì¸íŠ¸!\n| **Clinical Scenario** | **Probable Diagnosis** | **Next Best Step / Treatment** | **Key Feature to Look For** |\n| --- | --- | --- | --- |\n| **50ì„¸ ë‚¨ì„±, ì²« ë°œì‘ (First Seizure)** | **Brain Tumor** (until proven otherwise) | **Neuro-imaging (MRI/CT)** | ë‘í†µ, êµ­ì†Œ ì‹ ê²½í•™ì  ê²°ì† |\n| **ì†Œì•„, ìˆ˜ì—… ì¤‘ ë©ë•Œë¦¼, 20ì´ˆ ë¯¸ë§Œ** | **Absence Seizure** | **Ethosuximide** | **3Hz Spike & Wave**, No Post-ictal |\n| **ë°œì‘ 5ë¶„ ì´ìƒ ì§€ì†** | **Status Epilepticus** | **1. Lorazepam (IV)** -> **2. Fosphenytoin/Keppra** | 5ë¶„ ë„˜ìœ¼ë©´ ìì—° ì†Œì‹¤ ì•ˆ ë¨. ë‡Œ ì†ìƒ ì‹œì‘. |\n| **ì“°ëŸ¬ì§„ í›„ ì¦‰ì‹œ ì˜ì‹ ëª…ë£Œ (Crisp awakening)** | **Syncope (ì‹¤ì‹ )** | Cardiac Workup (ECG) | Post-ictal state ì—†ìŒ |\n| **ì“°ëŸ¬ì§„ í›„ 30ë¶„ê°„ í˜¼ë€ (Confusion)** | **Seizure** | Seizure Workup | **Post-ictal state ìˆìŒ (Gold Standard)** |\n| **ë°œì‘ í™˜ì, Phenytoin ë³µìš© ì¤‘, ë¹„í‹€ê±°ë¦¼/ì–´ì§€ëŸ¬ì›€** | **Phenytoin Toxicity** | Drug Level Check | **Horizontal Nystagmus**, Ataxia |\n| **Intubation í›„ ê²‰ë³´ê¸°ì—” ë©ˆì·„ìœ¼ë‚˜ ì˜ì‹ ì—†ìŒ** | **Non-convulsive Status** | **Continuous EEG** | ë‡ŒëŠ” ì—¬ì „íˆ íƒ€ê³  ìˆìŒ (Silent Seizure) |\n---\n### **ğŸ§  USMLE Ischemic Stroke: The \"Time is Brain\" Masterclass**","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-282","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **ğŸŒŸ Overview & TL;DR (Too Long; Didn't Read)**\n| **Concept** | **Key Point ğŸ—ï¸** |\n| --- | --- |\n| **Core Mantra** | **Time is Brain** (2 million neurons die/min) â±ï¸ğŸ§  |\n| **#1 Risk Factor** | **Hypertension** (The King ğŸ‘‘, 4x risk) |\n| **First Test** | **Non-Contrast CT Head** (Rule out bleed first!) ğŸš«ğŸ©¸ |\n| **TPA Window** | **< 3 ~ 4.5 Hours** (Check contraindications!) |\n| **BP Rules** | **Permissive HTN** (< 220/120) unless giving TPA (< 185/110) |\n| **Glucose** | Always check **Glucose** (<50 mimics stroke) ğŸ¬ |\n| **MCA Stroke** | Face/Arm > Leg, Gaze towards lesion ğŸ‘€ |\n| **ACA Stroke** | Leg/Foot > Arm, Urinary Incontinence ğŸ¦µğŸ’¦ |\n| **Lacunar** | Deep structures, **No cortical signs** (Pure Motor/Sensory) |\n| **CVST** | Pregnant/OCP, Seizure + Headache, Tx: **Heparin** |\n---\n### **ğŸŒ³ Top-Down Classification: Stroke Universe**\nPlaintext\n#\n`DISEASE: STROKE (Cerebrovascular Accident)\nâ”‚\nâ”œâ”€â”€ PATHOPHYSIOLOGY (Mechanism)\nâ”‚   â”œâ”€â”€ Ischemic (80-85%) - Blockage\nâ”‚   â”‚   â”œâ”€â”€ Thrombotic (Plaque rupture, stuttering onset)\nâ”‚   â”‚   â”œâ”€â”€ Embolic (Clot from heart/Afib, sudden max deficit)\nâ”‚   â”‚   â””â”€â”€ Lacunar (Small vessel, HTN/DM, deep structures)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Hemorrhagic (15-20%) - Bleeding [White on CT]\nâ”‚       â”œâ”€â”€ Intracerebral Hemorrhage (ICH)\nâ”‚       â””â”€â”€ Subarachnoid Hemorrhage (SAH) - \"Thunderclap\"\nâ”‚\nâ”œâ”€â”€ CLINICAL SYNDROMES (Anatomy)\nâ”‚   â”œâ”€â”€ Anterior Circulation\nâ”‚   â”‚   â”œâ”€â”€ MCA (Lateral: Face/Arm, Aphasia/Neglect)\nâ”‚   â”‚   â””â”€â”€ ACA (Medial: Leg/Foot, Motivation/Abulia)\nâ”‚   â”œâ”€â”€ Posterior Circulation (PCA, Vertebrobasilar)\nâ”‚   â””â”€â”€ Venous (CVST) - Young female, Hypercoagulable\nâ”‚\nâ””â”€â”€ MANAGEMENT PHASE\n    â”œâ”€â”€ Hyperacute (Doorway -> CT -> TPA decision)\n    â”œâ”€â”€ Acute (BP control, Workup: MRI, Echo, Carotids)\n    â””â”€â”€ Secondary Prevention (Antiplatelet, Statin, Risk factor control)`\n---\n### **1. ğŸš‘ Introduction & Pathophysiology: The Mechanics**\n**The \"Doorway\" Scenario:**\nì‘ê¸‰ì‹¤ ë¬¸ ì•ì—ì„œ ë³¸ 70ëŒ€ í™˜ì. í•œ ì‹œê°„ ì „ì—” ë©€ì©¡í–ˆëŠ”ë°(breakfast table), ì§€ê¸ˆì€ ì˜ìì— ë¬´ë„ˆì ¸ ë‚´ë¦¼(slumped). ì˜¤ë¥¸ìª½ íŒ”ì€ **Dead weight** (ì¶• ëŠ˜ì–´ì§), ëˆˆì€ ì™¼ìª½ìœ¼ë¡œ ê³ ì •ë¨. ë§ì„ ê±¸ì–´ë„ **Confused Silence** (ì¹¨ë¬µ).\n- ì´ê²ƒì´ ë°”ë¡œ Classic Acute Stroke.\n- **Time is Brain:** í˜ˆê´€ì´ ë§‰íŒ ë§¤ 1ë¶„ë§ˆë‹¤ **200ë§Œ ê°œì˜ ë‰´ëŸ°(2 million neurons)**ì´ ì‚¬ë§í•¨. í™˜ìì˜ ê¸°ì–µ, ì„±ê²©, ë§í•˜ëŠ” ëŠ¥ë ¥ì´ ì‹¤ì‹œê°„ìœ¼ë¡œ ì‚¬ë¼ì§€ëŠ” ì¤‘. ğŸ“‰\n**Risk Factors (The \"Public Enemy\"):**\n1. **Hypertension (HTN) ğŸ‘‘:** **The Absolute King.** Risk Multiplier **4x**. íŒŒì´í”„ì˜ ìˆ˜ì••ì´ ë„ˆë¬´ ì„¼ ê²ƒê³¼ ê°™ìŒ. í˜ˆê´€ ë²½ì„ ì§€ì†ì ìœ¼ë¡œ ê°‰ì•„ë¨¹ìŒ(Sandpapering).\n2. Smoking & Diabetes: ë‚˜ì˜ì§€ë§Œ, ê³ í˜ˆì••ì´ ì••ë„ì ì„.\n**Thrombotic vs. Embolic (Pipes vs. Cannonballs):**\n- **Thrombotic Stroke:**\n    - **Mechanism:** Atherosclerotic plaqueê°€ ë‡Œí˜ˆê´€ ë°”ë¡œ ê·¸ ìë¦¬ì—ì„œ í„°ì§.\n    - **Pattern:** **Stuttering Progression** (ê¹œë¹¡ì´ëŠ” ì „êµ¬ì²˜ëŸ¼ ì¦ìƒì´ ì¢‹ì•„ì¡Œë‹¤ ë‚˜ë¹ ì¡Œë‹¤ ë°˜ë³µ). ğŸ’¡ğŸ“‰\n- **Embolic Stroke:**\n    - **Mechanism:** ì‹¬ì¥(ì˜ˆ: Afib, Valve vegetation)ì—ì„œ ë‚ ì•„ì˜¨ í”¼ë–¡(Clot)ì´ ë‡Œí˜ˆê´€ì„ \"ëŒ€í¬ì•Œ(Cannonball)\"ì²˜ëŸ¼ ë•Œë¦¼.\n    - **Pattern:** **Abrupt, Maximal deficit at onset.** (ì‹œì‘í•˜ìë§ˆì ìµœì•…ì˜ ì¦ìƒ).\n---\n### **2. âš¡ TIA (Transient Ischemic Attack): The Warning Shot**\n**Concept:** \"ì‹œìŠ¤í…œ ì‹¤íŒ¨ê°€ ì•„ë‹ˆë¼, ìš´ì´ ì–µìˆ˜ë¡œ ì¢‹ì•˜ë˜ ì¼€ì´ìŠ¤(Lucky).\"\n- **Definition:** Ischemia(í—ˆí˜ˆ)ëŠ” ìˆì—ˆì§€ë§Œ Infarction(ì¡°ì§ ê´´ì‚¬)ì€ ì—†ëŠ” ìƒíƒœ. Clotì´ ì˜êµ¬ì  ì†ìƒì„ ì£¼ê¸° ì „ì— ë…¹ì•„ë²„ë¦¼. í•˜ì§€ë§Œ \"ì´ì€ ì—¬ì „íˆ ì¥ì „ë˜ì–´ ìˆìŒ(Gun is still loaded).\" ğŸ”«","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-292","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**Immediate Workup (3 Pillars):**\n1. **MRI Brain (DWI):** â˜… **Gold Standard.** CTë³´ë‹¤ í›¨ì”¬ ë¯¼ê°í•¨. ì§„ì§œ Strokeê°€ ìŠ¤ì¹˜ê³  ì§€ë‚˜ê°”ëŠ”ì§€ í™•ì¸.\n2. **Vascular Imaging (CTA/MRA):** ëª© í˜ˆê´€(Carotid)ì´ ë§‰í˜”ëŠ”ì§€ í™•ì¸. (Ticking Time Bomb í™•ì¸) ğŸ’£\n3. **Cardiac Monitoring:** ì‹¬ì¥ì—ì„œ ì˜¨ ê±´ì§€ í™•ì¸ (Afib ì°¾ê¸°).\n---\n### **3. ğŸ¥ Acute Management Algorithm (The Checklist)**\n**Step 1: The First Test**\n- **Non-Contrast CT Head:** â˜… **Next Best Step.**\n- **Why?** Ischemia(ë‡Œê²½ìƒ‰)ë¥¼ ë³´ë ¤ëŠ” ê²Œ ì•„ë‹ˆë¼, **Hemorrhage(ë‡Œì¶œí˜ˆ, White)**ë¥¼ **Rule out** í•˜ê¸° ìœ„í•¨! ğŸ©¸\n    - **White (Blood):** Stop everything. ë‡Œì¶œí˜ˆ í”„ë¡œí† ì½œ.\n    - **Black/Normal:** Ischemicìœ¼ë¡œ ê°„ì£¼í•˜ê³  TPA ê³ ë ¤.\n**Step 2: The Glucose Trap**\n- **Fingerstick Glucose:** ë°˜ë“œì‹œ ì²´í¬! ğŸ©¸ğŸ¬\n- **Why?** **Severe Hypoglycemia (<50)**ëŠ” Strokeì™€ ì¦ìƒì´ ë˜‘ê°™ìŒ(Focal weakness, confusion). ìƒŒë“œìœ„ì¹˜ë‘ ì˜¤ë Œì§€ ì£¼ìŠ¤ë§Œ ì£¼ë©´ ë‚«ëŠ” í™˜ìì—ê²Œ TPA(ì¶œí˜ˆ ìœ„í—˜ ìˆëŠ” ì•½)ë¥¼ ì£¼ë©´ ì•ˆ ë¨!\n**Step 3: The TPA Decision (Thrombolytics)**\n- **Concept:** ê°•ë ¥í•œ \"Clot Buster.\"\n- **Time Window:** ì¦ìƒ ë°œí˜„ í›„ **< 3 ~ 4.5 ì‹œê°„** ì´ë‚´. (Last known normal time ê¸°ì¤€).\n- **Major Contraindications (ì ˆëŒ€ ê¸ˆê¸°):**\n    - ë‡Œì¶œí˜ˆ ê³¼ê±°ë ¥ (Any history of ICH).\n    - ìµœê·¼ ìˆ˜ìˆ , ì™¸ìƒ, í™œë™ì„± ì¶œí˜ˆ.\n    - **BP > 185/110** (í˜ˆì••ì´ ë„ˆë¬´ ë†’ìœ¼ë©´ ì•½ ì£¼ë‹¤ê°€ ë‡Œì¶œí˜ˆ í„°ì§).\n**Step 4: Blood Pressure Management (The Tightrope)**\n- **Permissive Hypertension (í—ˆìš©ì  ê³ í˜ˆì••):**\n    - **Why?** ë‡Œì˜ **Penumbra** (ì£½ì–´ê°€ëŠ” ë‡Œì„¸í¬ ì£¼ë³€ë¶€, Stunned tissue)ë¥¼ ì‚´ë¦¬ê¸° ìœ„í•´. Collateral flow(ê³ê°€ì§€ í˜ˆê´€)ë¡œ í”¼ë¥¼ ë°€ì–´ë„£ìœ¼ë ¤ë©´ ë†’ì€ ì••ë ¥ì´ í•„ìš”í•¨.\n    - **Rule (No TPA):** TPAë¥¼ ì•ˆ ì“´ë‹¤ë©´ **220/120**ê¹Œì§€ëŠ” ê·¸ëƒ¥ ë‘ (Let it ride). ğŸ¢\n    - **Rule (With TPA):** TPAë¥¼ ì“´ë‹¤ë©´ ë¬´ì¡°ê±´ **< 185/110**ìœ¼ë¡œ ë‚®ì¶°ì•¼ í•¨ (Labetalol, Nicardipine ë“±ìœ¼ë¡œ). ì•ˆ ê·¸ëŸ¬ë©´ B\n**â˜ ï¸ Nightmare Complication: Hemorrhagic Transformation**\n- TPA íˆ¬ì—¬ í›„ í™˜ìê°€ ê°‘ìê¸° ë‘í†µ í˜¸ì†Œ(Headache), ì˜ì‹ ì €í•˜ ğŸ“‰.\n- **Action:** ì¦‰ì‹œ TPA ì¤‘ë‹¨ ğŸ›‘ -> Stat CT Head. (ë‡Œê²½ìƒ‰ì´ ë‡Œì¶œí˜ˆë¡œ ë°”ë€œ).\n---\n### **4. ğŸ—ºï¸ Stroke Syndromes: Anatomy is Destiny**\në‡Œì˜ ì§€ë„ë¥¼ ê·¸ë ¤ì•¼ í•¨. **Homunculus** (ë‡Œ í‘œë©´ì˜ ì‹ ì²´ ì§€ë„).\n- **Lateral (ë°”ê¹¥ìª½):** ì–¼êµ´(Face), íŒ”(Arm), ì†.\n- **Medial (ì•ˆìª½/MOHAWK ë¼ì¸):** ë‹¤ë¦¬(Leg), ë°œ(Foot), ì„±ê¸°(Genitals).\n### **A. MCA (Middle Cerebral Artery) Stroke - Most Common**\n- **Territory:** Lateral Surface.\n- **Symptoms:**\n    - **Contralateral Face & Arm Weakness > Leg.** (ì–¼êµ´/íŒ”ì´ ë‹¤ë¦¬ë³´ë‹¤ ì‹¬í•¨).\n    - **Gaze Preference:** ë³‘ë³€ì´ ìˆëŠ” ìª½ì„ ì³ë‹¤ë´„ (**Look *towards* the lesion**). ğŸ‘€ (Frontal Eye Field ì†ìƒìœ¼ë¡œ ë°˜ëŒ€ìª½ ëˆˆ ê·¼ìœ¡ì´ ì´ê²¨ë¨¹ìŒ).\n    - **Dominant Hemisphere (Left):** **Aphasia** (Broca's - ë§ ëª»í•¨ / Wernicke's - ë§ ì´í•´ ëª»í•¨). ğŸ—£ï¸âŒ\n    - **Non-Dominant Hemisphere (Right):** **Hemineglect** (ì™¼ìª½ ì„¸ìƒì„ ë¬´ì‹œí•¨. ì™¼ìª½ ìˆ˜ì—¼ë§Œ ì•ˆ ê¹ìŒ).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-312","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"### **B. ACA (Anterior Cerebral Artery) Stroke**\n- **Territory:** Medial Surface (Mohawk area).\n- **Symptoms:**\n    - **Contralateral Leg & Foot Weakness > Arm.** (ë‹¤ë¦¬ê°€ íŒ”ë³´ë‹¤ ì‹¬í•¨). ğŸ¦µ\n    - **Urinary Incontinence:** ì†Œë³€ ì¡°ì ˆ ì¤‘ì¶”(Paracentral lobule) ì¹¨ë²”. ğŸš½\n    - **Abulia:** ì˜ìš• ìƒì‹¤, ë¬´ê¸°ë ¥ (Motivation center ì¹¨ë²”).\n### **C. Lacunar Strokes (Small Vessel Disease)**\n- **Pathology:** **Lipohyalinosis / Microatheroma.** ê³ í˜ˆì••/ë‹¹ë‡¨ë¡œ ì¸í•´ ë‡Œ ê¹Šì€ ê³³(Internal Capsule, Thalamus)ì˜ ë¯¸ì„¸ í˜ˆê´€ì´ \"ë…¹ìŠ¨ íŒŒì´í”„\"ì²˜ëŸ¼ ë§‰í˜.\n- **Key Feature:** **Absence of Cortical Signs.** (í”¼ì§ˆ ì¦ìƒì´ ì—†ìŒ).\n    - No Aphasia, No Neglect, No Vision Loss. âŒğŸ—£ï¸\n- **Types:**\n    - **Pure Motor:** Internal Capsule (Posterior limb). íŒ”/ë‹¤ë¦¬/ì–¼êµ´ ê· ë“±í•˜ê²Œ ë§ˆë¹„.\n    - **Pure Sensory:** Thalamus (VPL). ë°˜ëŒ€ìª½ ëª¸ ì „ì²´ ì €ë¦¼(Numbness).\n---\n### **5. ğŸ’£ Malignant Hemispheric Infarction (MHI)**\n- **Scenario:** ì•„ì£¼ í° MCA Stroke ë°œìƒ -> ë‡Œì˜ ì ˆë°˜ì´ ì£½ìŒ -> 3~5ì¼ ë’¤ ê´´ì‚¬ëœ ì¡°ì§ì´ ì—„ì²­ë‚˜ê²Œ ë¶€ì–´ì˜¤ë¦„(**Edema**).\n- **Problem:** ë‘ê°œê³¨(Skull)ì€ ë‹«íŒ ìƒìì„. ë¶€ì„ ê³µê°„ì´ ì—†ì–´ì„œ **Herniation** (ë‡Œê°€ ëˆŒë ¤ì„œ ë¹ ì ¸ë‚˜ì˜´) -> Brainstem ì••ë°• -> ì‚¬ë§. â˜ ï¸\n- **Treatment:** **Decompressive Hemicraniectomy.** ğŸ”¨\n    - ë‘ê°œê³¨ì„ í¬ê²Œ ì˜ë¼ë‚´ì–´ ë‡Œê°€ ë°–ìœ¼ë¡œ ë¶€ì–´ì˜¤ë¥¼ ìˆ˜ ìˆê²Œ ìˆ¨í†µì„ íŠ¸ì—¬ì¤Œ. (Closed box -> Open box). ìƒëª…ì„ ì‚´ë¦¬ëŠ” ì‹œìˆ .\n---\n### **6. ğŸŒŠ Cerebral Venous Sinus Thrombosis (CVST)**\n**\"The Curveball Diagnosis\"**\n- ë™ë§¥(Artery)ì´ ì•„ë‹ˆë¼ **ì •ë§¥(Vein)**ì´ ë§‰íŒ ê²ƒ. í•˜ìˆ˜êµ¬ê°€ ë§‰í˜€ì„œ ì—­ë¥˜í•˜ëŠ” ìƒí™©.\n- **Patient Profile:** ì Šì€ ì—¬ì„±, **Hypercoagulable state** (ì„ì‹ , ì¶œì‚° í›„, í”¼ì„ì•½-OCP ë³µìš©, í¡ì—°). ğŸ¤°ğŸ’ŠğŸš¬\n- **Symptoms:**\n    - **Headache:** ì ì  ì‹¬í•´ì§€ê±°ë‚˜ ë²¼ë½ë‘í†µ(Thunderclap).\n    - **Seizures:** í”í•¨.\n    - **Papilledema:** ë‡Œì•• ìƒìŠ¹ ì†Œê²¬.\n- **Diagnosis:** â˜… **MR Venography (MRV).** ì •ë§¥ì˜ íë¦„ì„ ë´ì•¼ í•¨.\n- **Treatment:** â˜… **Heparin (Anticoagulation).**\n    - **Paradox:** ì •ë§¥ì´ ë§‰í˜€ì„œ í„°ì§€ë©´ ì•½ê°„ì˜ ì¶œí˜ˆì´ ë³´ì¼ ìˆ˜ ìˆìŒ. ê·¸ë˜ë„ í—¤íŒŒë¦°ì„ ì¨ì•¼ í•¨? **YES!** âœ…\n    - **Why?** ì¶œí˜ˆì˜ ì›ì¸ì´ \"í•˜ìˆ˜êµ¬ê°€ ë§‰í˜€ì„œ ì••ë ¥ì´ ì°¼ê¸° ë•Œë¬¸\"ì´ë¯€ë¡œ, í•˜ìˆ˜êµ¬(Clot)ë¥¼ ëš«ì–´ì¤˜ì•¼ ì¶œí˜ˆë„ ë©ˆì¶¤.\n---\n### **7. ğŸ”º Cavernous Sinus Thrombosis**\n**\"The Danger Triangle\"** âš ï¸\n- **Pathology:** ì–¼êµ´ì˜ \"Danger Triangle\" (ì½”~ì…ìˆ  ì£¼ë³€)ì— ì—¬ë“œë¦„(Pimple)ì„ ì§°ëŠ”ë°, ê·¸ ì„¸ê· ì´ ì •ë§¥ì„ íƒ€ê³  ë‡Œ ì†ì˜ Cavernous Sinusë¡œ ë“¤ì–´ê°.\n- **Anatomy:** Cavernous Sinus ì•ˆì—ëŠ” **CN 3, 4, V1, V2, 6**ë²ˆ ì‹ ê²½ê³¼ Internal Carotid Arteryê°€ ì§€ë‚˜ê°.\n- **Symptoms:**\n    - **Proptosis:** ëˆˆì´ íŠ€ì–´ë‚˜ì˜´. ğŸ‘€\n    - **Ophthalmoplegia:** ëˆˆì„ ëª» ì›€ì§ì„ (CN 3, 4, 6 ë§ˆë¹„).\n    - **Sensory Loss:** ì´ë§ˆ/ëº¨ ê°ê° ì €í•˜ (CN V1, V2).\n    - ì¦ìƒì´ í•œìª½ì—ì„œ ì‹œì‘í•´ **ì–‘ìª½(Bilateral)**ìœ¼ë¡œ ê¸‰ì†íˆ í¼ì§ (Sinusê°€ ì—°ê²°ë˜ì–´ ìˆì–´ì„œ).\n---","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-332","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### **ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| **Face/Arm > Leg Weakness** | **MCA Stroke** (Lateral) |\n| **Leg/Foot > Arm Weakness** | **ACA Stroke** (Medial) |\n| **Gaze Preference** | Looks **Towards** the lesion (PPRF/FEF) |\n| **Aphasia (Speech issue)** | **Left** MCA (Dominant) |\n| **Hemineglect (Ignores left side)** | **Right** MCA (Non-dominant) |\n| **Pure Motor or Sensory (No cortical signs)** | **Lacunar Stroke** (Deep structures) |\n| **Young Female + OCP + Seizure/HA** | **CVST** (Check MRV!) |\n| **Focal Neuro Deficit + Hypoglycemia** | **Stroke Mimic** (Give Glucose!) ğŸ¬ |\n| **TPA BP Limit** | Must be **< 185/110** |\n| **No TPA BP Limit** | Permissive up to **220/120** |\n**ğŸ’¡ Final Wisdom:**\n\"Stroke managementëŠ” **Balance** ì‹¸ì›€ì…ë‹ˆë‹¤. í˜ˆì••ì„ ë„ˆë¬´ ë‚®ì¶”ë©´ ë‡Œê°€ ë§ˆë¥´ê³ (Ischemia), ë„ˆë¬´ ë†’ìœ¼ë©´ í„°ì§‘ë‹ˆë‹¤(Bleed). Time is Brain. ë§ì„¤ì´ì§€ ë§ê³  4.5ì‹œê°„ ìœˆë„ìš°ë¥¼ ì‚¬ìˆ˜í•˜ì„¸ìš”!\" ğŸš€\n### **ğŸ§  USMLE Ischemic Stroke: The \"Time is Brain\" Masterclass**\n### **ğŸŒŸ Overview & TL;DR (Too Long; Didn't Read)**\n| **Concept** | **Key Point ğŸ—ï¸** |\n| --- | --- |\n| **Core Mantra** | **Time is Brain** (2 million neurons die/min) â±ï¸ğŸ§  |\n| **#1 Risk Factor** | **Hypertension** (The King ğŸ‘‘, 4x risk) |\n| **First Test** | **Non-Contrast CT Head** (Rule out bleed first!) ğŸš«ğŸ©¸ |\n| **TPA Window** | **< 3 ~ 4.5 Hours** (Check contraindications!) |\n| **BP Rules** | **Permissive HTN** (< 220/120) unless giving TPA (< 185/110) |\n| **Glucose** | Always check **Glucose** (<50 mimics stroke) ğŸ¬ |\n| **MCA Stroke** | Face/Arm > Leg, Gaze towards lesion ğŸ‘€ |\n| **ACA Stroke** | Leg/Foot > Arm, Urinary Incontinence ğŸ¦µğŸ’¦ |\n| **Lacunar** | Deep structures, **No cortical signs** (Pure Motor/Sensory) |\n| **CVST** | Pregnant/OCP, Seizure + Headache, Tx: **Heparin** |","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-348","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"---\n### **ğŸŒ³ Top-Down Classification: Stroke Universe**\n`DISEASE: STROKE (Cerebrovascular Accident)\nâ”‚\nâ”œâ”€â”€ PATHOPHYSIOLOGY (Mechanism)\nâ”‚   â”œâ”€â”€ Ischemic (80-85%) - Blockage\nâ”‚   â”‚   â”œâ”€â”€ Thrombotic (Plaque rupture, stuttering onset)\nâ”‚   â”‚   â”œâ”€â”€ Embolic (Clot from heart/Afib, sudden max deficit)\nâ”‚   â”‚   â””â”€â”€ Lacunar (Small vessel, HTN/DM, deep structures)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Hemorrhagic (15-20%) - Bleeding [White on CT]\nâ”‚       â”œâ”€â”€ Intracerebral Hemorrhage (ICH)\nâ”‚       â””â”€â”€ Subarachnoid Hemorrhage (SAH) - \"Thunderclap\"\nâ”‚\nâ”œâ”€â”€ CLINICAL SYNDROMES (Anatomy)\nâ”‚   â”œâ”€â”€ Anterior Circulation\nâ”‚   â”‚   â”œâ”€â”€ MCA (Lateral: Face/Arm, Aphasia/Neglect)\nâ”‚   â”‚   â””â”€â”€ ACA (Medial: Leg/Foot, Motivation/Abulia)\nâ”‚   â”œâ”€â”€ Posterior Circulation (PCA, Vertebrobasilar)\nâ”‚   â””â”€â”€ Venous (CVST) - Young female, Hypercoagulable\nâ”‚\nâ””â”€â”€ MANAGEMENT PHASE\n    â”œâ”€â”€ Hyperacute (Doorway -> CT -> TPA decision)\n    â”œâ”€â”€ Acute (BP control, Workup: MRI, Echo, Carotids)\n    â””â”€â”€ Secondary Prevention (Antiplatelet, Statin, Risk factor control)`\n---\n### **1. ğŸš‘ Introduction & Pathophysiology: The Mechanics**\n**The \"Doorway\" Scenario:**\nì‘ê¸‰ì‹¤ ë¬¸ ì•ì—ì„œ ë³¸ 70ëŒ€ í™˜ì. í•œ ì‹œê°„ ì „ì—” ë©€ì©¡í–ˆëŠ”ë°(breakfast table), ì§€ê¸ˆì€ ì˜ìì— ë¬´ë„ˆì ¸ ë‚´ë¦¼(slumped). ì˜¤ë¥¸ìª½ íŒ”ì€ **Dead weight** (ì¶• ëŠ˜ì–´ì§), ëˆˆì€ ì™¼ìª½ìœ¼ë¡œ ê³ ì •ë¨. ë§ì„ ê±¸ì–´ë„ **Confused Silence** (ì¹¨ë¬µ).\n- ì´ê²ƒì´ ë°”ë¡œ Classic Acute Stroke.\n- **Time is Brain:** í˜ˆê´€ì´ ë§‰íŒ ë§¤ 1ë¶„ë§ˆë‹¤ **200ë§Œ ê°œì˜ ë‰´ëŸ°(2 million neurons)**ì´ ì‚¬ë§í•¨. í™˜ìì˜ ê¸°ì–µ, ì„±ê²©, ë§í•˜ëŠ” ëŠ¥ë ¥ì´ ì‹¤ì‹œê°„ìœ¼ë¡œ ì‚¬ë¼ì§€ëŠ” ì¤‘. ğŸ“‰\n**Risk Factors (The \"Public Enemy\"):**\n1. **Hypertension (HTN) ğŸ‘‘:** **The Absolute King.** Risk Multiplier **4x**. íŒŒì´í”„ì˜ ìˆ˜ì••ì´ ë„ˆë¬´ ì„¼ ê²ƒê³¼ ê°™ìŒ. í˜ˆê´€ ë²½ì„ ì§€ì†ì ìœ¼ë¡œ ê°‰ì•„ë¨¹ìŒ(Sandpapering).\n2. Smoking & Diabetes: ë‚˜ì˜ì§€ë§Œ, ê³ í˜ˆì••ì´ ì••ë„ì ì„.\n**Thrombotic vs. Embolic (Pipes vs. Cannonballs):**\n- **Thrombotic Stroke:**\n    - **Mechanism:** Atherosclerotic plaqueê°€ ë‡Œí˜ˆê´€ ë°”ë¡œ ê·¸ ìë¦¬ì—ì„œ í„°ì§.\n    - **Pattern:** **Stuttering Progression** (ê¹œë¹¡ì´ëŠ” ì „êµ¬ì²˜ëŸ¼ ì¦ìƒì´ ì¢‹ì•„ì¡Œë‹¤ ë‚˜ë¹ ì¡Œë‹¤ ë°˜ë³µ). ğŸ’¡ğŸ“‰\n- **Embolic Stroke:**\n    - **Mechanism:** ì‹¬ì¥(ì˜ˆ: Afib, Valve vegetation)ì—ì„œ ë‚ ì•„ì˜¨ í”¼ë–¡(Clot)ì´ ë‡Œí˜ˆê´€ì„ \"ëŒ€í¬ì•Œ(Cannonball)\"ì²˜ëŸ¼ ë•Œë¦¼.\n    - **Pattern:** **Abrupt, Maximal deficit at onset.** (ì‹œì‘í•˜ìë§ˆì ìµœì•…ì˜ ì¦ìƒ).\n---\n### **2. âš¡ TIA (Transient Ischemic Attack): The Warning Shot**\n**Concept:** \"ì‹œìŠ¤í…œ ì‹¤íŒ¨ê°€ ì•„ë‹ˆë¼, ìš´ì´ ì–µìˆ˜ë¡œ ì¢‹ì•˜ë˜ ì¼€ì´ìŠ¤(Lucky).\"\n- **Definition:** Ischemia(í—ˆí˜ˆ)ëŠ” ìˆì—ˆì§€ë§Œ Infarction(ì¡°ì§ ê´´ì‚¬)ì€ ì—†ëŠ” ìƒíƒœ. Clotì´ ì˜êµ¬ì  ì†ìƒì„ ì£¼ê¸° ì „ì— ë…¹ì•„ë²„ë¦¼. í•˜ì§€ë§Œ \"ì´ì€ ì—¬ì „íˆ ì¥ì „ë˜ì–´ ìˆìŒ(Gun is still loaded).\" ğŸ”«\n**Immediate Workup (3 Pillars):**\n1. **MRI Brain (DWI):** â˜… **Gold Standard.** CTë³´ë‹¤ í›¨ì”¬ ë¯¼ê°í•¨. ì§„ì§œ Strokeê°€ ìŠ¤ì¹˜ê³  ì§€ë‚˜ê°”ëŠ”ì§€ í™•ì¸.\n2. **Vascular Imaging (CTA/MRA):** ëª© í˜ˆê´€(Carotid)ì´ ë§‰í˜”ëŠ”ì§€ í™•ì¸. (Ticking Time Bomb í™•ì¸) ğŸ’£\n3. **Cardiac Monitoring:** ì‹¬ì¥ì—ì„œ ì˜¨ ê±´ì§€ í™•ì¸ (Afib ì°¾ê¸°).\n---\n### **3. ğŸ¥ Acute Management Algorithm (The Checklist)**","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-358","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"**Step 1: The First Test**\n- **Non-Contrast CT Head:** â˜… **Next Best Step.**\n- **Why?** Ischemia(ë‡Œê²½ìƒ‰)ë¥¼ ë³´ë ¤ëŠ” ê²Œ ì•„ë‹ˆë¼, **Hemorrhage(ë‡Œì¶œí˜ˆ, White)**ë¥¼ **Rule out** í•˜ê¸° ìœ„í•¨! ğŸ©¸\n    - **White (Blood):** Stop everything. ë‡Œì¶œí˜ˆ í”„ë¡œí† ì½œ.\n    - **Black/Normal:** Ischemicìœ¼ë¡œ ê°„ì£¼í•˜ê³  TPA ê³ ë ¤.\n**Step 2: The Glucose Trap**\n- **Fingerstick Glucose:** ë°˜ë“œì‹œ ì²´í¬! ğŸ©¸ğŸ¬\n- **Why?** **Severe Hypoglycemia (<50)**ëŠ” Strokeì™€ ì¦ìƒì´ ë˜‘ê°™ìŒ(Focal weakness, confusion). ìƒŒë“œìœ„ì¹˜ë‘ ì˜¤ë Œì§€ ì£¼ìŠ¤ë§Œ ì£¼ë©´ ë‚«ëŠ” í™˜ìì—ê²Œ TPA(ì¶œí˜ˆ ìœ„í—˜ ìˆëŠ” ì•½)ë¥¼ ì£¼ë©´ ì•ˆ ë¨!\n**Step 3: The TPA Decision (Thrombolytics)**\n- **Concept:** ê°•ë ¥í•œ \"Clot Buster.\"\n- **Time Window:** ì¦ìƒ ë°œí˜„ í›„ **< 3 ~ 4.5 ì‹œê°„** ì´ë‚´. (Last known normal time ê¸°ì¤€).\n- **Major Contraindications (ì ˆëŒ€ ê¸ˆê¸°):**\n    - ë‡Œì¶œí˜ˆ ê³¼ê±°ë ¥ (Any history of ICH).\n    - ìµœê·¼ ìˆ˜ìˆ , ì™¸ìƒ, í™œë™ì„± ì¶œí˜ˆ.\n    - **BP > 185/110** (í˜ˆì••ì´ ë„ˆë¬´ ë†’ìœ¼ë©´ ì•½ ì£¼ë‹¤ê°€ ë‡Œì¶œí˜ˆ í„°ì§).\n**Step 4: Blood Pressure Management (The Tightrope)**\n- **Permissive Hypertension (í—ˆìš©ì  ê³ í˜ˆì••):**\n    - **Why?** ë‡Œì˜ **Penumbra** (ì£½ì–´ê°€ëŠ” ë‡Œì„¸í¬ ì£¼ë³€ë¶€, Stunned tissue)ë¥¼ ì‚´ë¦¬ê¸° ìœ„í•´. Collateral flow(ê³ê°€ì§€ í˜ˆê´€)ë¡œ í”¼ë¥¼ ë°€ì–´ë„£ìœ¼ë ¤ë©´ ë†’ì€ ì••ë ¥ì´ í•„ìš”í•¨.\n    - **Rule (No TPA):** TPAë¥¼ ì•ˆ ì“´ë‹¤ë©´ **220/120**ê¹Œì§€ëŠ” ê·¸ëƒ¥ ë‘ (Let it ride). ğŸ¢\n    - **Rule (With TPA):** TPAë¥¼ ì“´ë‹¤ë©´ ë¬´ì¡°ê±´ **< 185/110**ìœ¼ë¡œ ë‚®ì¶°ì•¼ í•¨ (Labetalol, Nicardipine ë“±ìœ¼ë¡œ). ì•ˆ ê·¸ëŸ¬ë©´ Brain Bleed í„°ì§.\n**â˜ ï¸ Nightmare Complication: Hemorrhagic Transformation**\n- TPA íˆ¬ì—¬ í›„ í™˜ìê°€ ê°‘ìê¸° ë‘í†µ í˜¸ì†Œ(Headache), ì˜ì‹ ì €í•˜ ğŸ“‰.\n- **Action:** ì¦‰ì‹œ TPA ì¤‘ë‹¨ ğŸ›‘ -> Stat CT Head. (ë‡Œê²½ìƒ‰ì´ ë‡Œì¶œí˜ˆë¡œ ë°”ë€œ).\n---\n### **4. ğŸ—ºï¸ Stroke Syndromes: Anatomy is Destiny**\në‡Œì˜ ì§€ë„ë¥¼ ê·¸ë ¤ì•¼ í•¨. **Homunculus** (ë‡Œ í‘œë©´ì˜ ì‹ ì²´ ì§€ë„).\n- **Lateral (ë°”ê¹¥ìª½):** ì–¼êµ´(Face), íŒ”(Arm), ì†.\n- **Medial (ì•ˆìª½/MOHAWK ë¼ì¸):** ë‹¤ë¦¬(Leg), ë°œ(Foot), ì„±ê¸°(Genitals).\n### **A. MCA (Middle Cerebral Artery) Stroke - Most Common**\n- **Territory:** Lateral Surface.\n- **Symptoms:**\n    - **Contralateral Face & Arm Weakness > Leg.** (ì–¼êµ´/íŒ”ì´ ë‹¤ë¦¬ë³´ë‹¤ ì‹¬í•¨).\n    - **Gaze Preference:** ë³‘ë³€ì´ ìˆëŠ” ìª½ì„ ì³ë‹¤ë´„ (**Look *towards* the lesion**). ğŸ‘€ (Frontal Eye Field ì†ìƒìœ¼ë¡œ ë°˜ëŒ€ìª½ ëˆˆ ê·¼ìœ¡ì´ ì´ê²¨ë¨¹ìŒ).\n    - **Dominant Hemisphere (Left):** **Aphasia** (Broca's - ë§ ëª»í•¨ / Wernicke's - ë§ ì´í•´ ëª»í•¨). ğŸ—£ï¸âŒ\n    - **Non-Dominant Hemisphere (Right):** **Hemineglect** (ì™¼ìª½ ì„¸ìƒì„ ë¬´ì‹œí•¨. ì™¼ìª½ ìˆ˜ì—¼ë§Œ ì•ˆ ê¹ìŒ).\n### **B. ACA (Anterior Cerebral Artery) Stroke**\n- **Territory:** Medial Surface (Mohawk area).\n- **Symptoms:**\n    - **Contralateral Leg & Foot Weakness > Arm.** (ë‹¤ë¦¬ê°€ íŒ”ë³´ë‹¤ ì‹¬í•¨). ğŸ¦µ\n    - **Urinary Incontinence:** ì†Œë³€ ì¡°ì ˆ ì¤‘ì¶”(Paracentral lobule) ì¹¨ë²”. ğŸš½\n    - **Abulia:** ì˜ìš• ìƒì‹¤, ë¬´ê¸°ë ¥ (Motivation center ì¹¨ë²”).\n### **C. Lacunar Strokes (Small Vessel Disease)**\n- **Pathology:** **Lipohyalinosis / Microatheroma.** ê³ í˜ˆì••/ë‹¹ë‡¨ë¡œ ì¸í•´ ë‡Œ ê¹Šì€ ê³³(Internal Capsule, Thalamus)ì˜ ë¯¸ì„¸ í˜ˆê´€ì´ \"ë…¹ìŠ¨ íŒŒì´í”„\"ì²˜ëŸ¼ ë§‰í˜.\n- **Key Feature:** **Absence of Cortical Signs.** (í”¼ì§ˆ ì¦ìƒì´ ì—†ìŒ).\n    - No Aphasia, No Neglect, No Vision Loss. âŒğŸ—£ï¸\n- **Types:**\n    - **Pure Motor:** Internal Capsule (Posterior limb). íŒ”/ë‹¤ë¦¬/ì–¼êµ´ ê· ë“±í•˜ê²Œ ë§ˆë¹„.\n    - **Pure Sensory:** Thalamus (VPL). ë°˜ëŒ€ìª½ ëª¸ ì „ì²´ ì €ë¦¼(Numbness).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-378","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment","tree"]}
